Biogen Inc (BIIB)
146.47
-0.92
(-0.62%)
USD |
NASDAQ |
Dec 20, 16:00
147.55
+1.08
(+0.74%)
After-Hours: 20:00
Biogen Market Cap: 21.34B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly and Co | 728.85B |
| Pfizer Inc | 149.38B |
| Regeneron Pharmaceuticals Inc | 77.13B |
| Sage Therapeutics Inc | 343.18M |
| Moderna Inc | 15.16B |
Market Cap Related Metrics
| PE Ratio | 13.23 |
| PS Ratio | 2.225 |
| PEG Ratio | 1.318 |
| Price to Book Value | 1.305 |
| Price to Free Cash Flow | 12.09 |
| Price | 146.47 |
| Earnings Yield | 7.56% |
| PEGY Ratio | 1.318 |
| Operating PE Ratio | 9.604 |
| Normalized PE Ratio | 12.39 |